-
develop more efficacious methods for the diagnosis and treatment of liver cancer. We are particularly interested in molecularly targeted diagnostic and therapeutic approaches, with the goal of translating
-
advances have been made in the treatment of melanoma and other checkpoint-responsive cancers, however, overall response is inadequate and significant adverse event rate remains high. Currently, there are no
-
Postdoctoral fellows in cancer epidemiology to conduct real-world evidence studies in oncology using causal inference methods to examine efficient surveillance and treatment strategies using
-
been made in the treatment of melanoma and other checkpoint-responsive cancers, however, overall response is inadequate and significant adverse event rate remains high. Currently, there are no reliable
-
The Stanford Urologic Cancer Epidemiology Lab, led by Associate Professor of Urology Dr. Benjamin I. Chung at Stanford University, is seeking a talented scientist to join the research team. Kidney
-
models to enable improved diagnosis, prognostication, and prediction of treatment response for bladder cancer, specifically related to endoscopic imaging and surgery. The postdoctoral scholar will be co
-
Our lab is leveraging a new methylation profiler that enriches methylation markers genome-wide to find diagnostic, prognostic markers for cancer and other diseases. The postdoctoral fellow should be
-
disparities in prevention and treatment outcomes for diabetes and cancer. These projects leverage big data analytics and qualitative and community engagement methodologies. Trainees with experience with
-
experiments. This position is fully-onsite. *- Other duties may also be assigned. DESIRED QUALIFICATIONS: Prefer a degree in the Neurobiology, Cancer Biology, Bioengineering, Biological Sciences. He/she must
-
and experience of the successful candidate. The successful applicant should have an established or emerging track record in the field of pancreatitis, pancreatic cancer, diabetes, pancreatic